Serum neuron-specific enolase level is an independent predictor of overall survival in patients with gastroenteropancreatic neuroendocrine tumors.

Autor: van Adrichem RC; Department of Internal Medicine, Sector of Endocrinology, ENETS Centre of Excellence for Neuroendocrine Tumors, Erasmus MC, Rotterdam, The Netherlands., Kamp K; Department of Internal Medicine, Sector of Endocrinology, ENETS Centre of Excellence for Neuroendocrine Tumors, Erasmus MC, Rotterdam, The Netherlands., Vandamme T; Department of Oncology, University of Antwerp, Antwerp, Belgium., Peeters M; Department of Oncology, University of Antwerp, Antwerp, Belgium., Feelders RA; Department of Internal Medicine, Sector of Endocrinology, ENETS Centre of Excellence for Neuroendocrine Tumors, Erasmus MC, Rotterdam, The Netherlands., de Herder WW; Department of Internal Medicine, Sector of Endocrinology, ENETS Centre of Excellence for Neuroendocrine Tumors, Erasmus MC, Rotterdam, The Netherlands w.w.deherder@erasmusmc.nl.
Jazyk: angličtina
Zdroj: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2016 Apr; Vol. 27 (4), pp. 746-7. Date of Electronic Publication: 2015 Dec 27.
DOI: 10.1093/annonc/mdv626
Databáze: MEDLINE